Olaplex upgraded by Piper Sandler with a new price target
$OLPX
Package Goods/Cosmetics
Consumer Discretionary
Piper Sandler upgraded Olaplex from Underweight to Neutral and set a new price target of $2.00 from $1.25 previously
Save time and jump to the most important pieces.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 8/7/2024 | $2.00 → $3.00 | Market Perform | Telsey Advisory Group |
| 3/19/2024 | $1.25 → $2.00 | Underweight → Neutral | Piper Sandler |
| 10/4/2023 | Underweight → Equal Weight | Barclays | |
| 8/25/2023 | $3.00 → $2.00 | Neutral → Underweight | Piper Sandler |
| 8/11/2023 | $5.00 → $3.00 | Buy → Hold | Canaccord Genuity |
| 8/9/2023 | $6.00 → $4.00 | Outperform → Market Perform | Telsey Advisory Group |
| 3/16/2023 | $10.00 → $4.50 | Outperform → Market Perform | TD Cowen |
| 3/1/2023 | $6.00 | Buy → Neutral | Goldman |
NEW YORK, April 24, 2025 (GLOBE NEWSWIRE) -- Olaplex Holdings, Inc. ("OLAPLEX"), today announced that it plans to report first quarter fiscal 2025 financial results before the market opens on Thursday, May 8, 2025. The company plans to host an investor conference call and webcast to review first quarter fiscal 2025 financial results at 9:00am ET/6:00am PT on the same day. The webcast can be accessed at https://ir.olaplex.com/. The conference call can be accessed by calling (201) 689-8521 or (877) 407-8813 for a toll-free number. A replay of the webcast will remain available on the website for 90 days. About OLAPLEX OLAPLEX is a foundational health and beauty company powered by breakthrou
NEW YORK, NY, March 04, 2025 (GLOBE NEWSWIRE) -- Olaplex Holdings, Inc. (NASDAQ:OLPX) ("OLAPLEX" or the "Company") today announced financial results for the fourth quarter and fiscal year ended December 31, 2024. Amanda Baldwin, OLAPLEX's Chief Executive Officer, commented: "I am pleased with our end to the year with our fourth quarter results ahead of the expectations we shared in November. During 2024 we laid a critical foundation for our business and brand transformation and I remain confident and optimistic about the strategies put in place as we step into a meaningful year ahead for the business." For the fourth quarter of 2024 compared to the fourth quarter of 2023: Net sales decr
NEW YORK, Feb. 26, 2025 (GLOBE NEWSWIRE) -- Olaplex Holdings, Inc. ("OLAPLEX"), today announced its participation in the Raymond James 46th Annual Institutional Investors Conference being held at the JW Marriott Orlando Grande Lakes in Orlando, Florida. Amanda Baldwin, Chief Executive Officer, and Catherine Dunleavy, Chief Operating Officer and Chief Financial Officer, will host a presentation on Wednesday, March 5, 2025 at 9:50am ET and hold meetings with investors throughout the day. The audio portion of the presentation will be available on the Company's Investor Relations website, https://ir.olaplex.com/, and will remain there for 90 days following the event. About OLAPLEX OLAPLEX is
Telsey Advisory Group reiterated coverage of Olaplex with a rating of Market Perform and set a new price target of $3.00 from $2.00 previously
Piper Sandler upgraded Olaplex from Underweight to Neutral and set a new price target of $2.00 from $1.25 previously
Barclays upgraded Olaplex from Underweight to Equal Weight
SC 13G/A - OLAPLEX HOLDINGS, INC. (0001868726) (Subject)
SC 13G/A - OLAPLEX HOLDINGS, INC. (0001868726) (Subject)
SC 13G - OLAPLEX HOLDINGS, INC. (0001868726) (Subject)